The estimated Net Worth of Albert Seymour is at least $3.67 millió dollars as of 6 September 2023. Mr. Seymour owns over 4,620 units of Homology Medicines Inc stock worth over $141,659 and over the last 7 years he sold FIXX stock worth over $1,647,082. In addition, he makes $1,876,830 as Chief Scientific Officer at Homology Medicines Inc.
Albert has made over 13 trades of the Homology Medicines Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 4,620 units of FIXX stock worth $4,297 on 6 September 2023.
The largest trade he's ever made was selling 18,600 units of Homology Medicines Inc stock on 29 November 2019 worth over $300,390. On average, Albert trades about 6,149 units every 78 days since 2018. As of 6 September 2023 he still owns at least 152,322 units of Homology Medicines Inc stock.
You can see the complete history of Mr. Seymour stock trades at the bottom of the page.
Albert Seymour Ph.D. serves as Chief Scientific Officer of the Company. Prior to joining Homology, Dr. Seymour was Senior Vice President, Head of Global Research and Nonclinical Development at Shire plc, a biotechnology company, from 2011 to 2016. Dr. Seymour received his B.A. in Biology from the University of Delaware, an M.S. from Johns Hopkins University School of Medicine and his Ph.D. in Human Genetics from the University of Pittsburgh.
As the Chief Scientific Officer of Homology Medicines Inc, the total compensation of Albert Seymour at Homology Medicines Inc is $1,876,830. There are 2 executives at Homology Medicines Inc getting paid more, with Arthur Tzianabos having the highest compensation of $5,062,880.
Albert Seymour is 52, he's been the Chief Scientific Officer of Homology Medicines Inc since 2016. There are 12 older and 4 younger executives at Homology Medicines Inc. The oldest executive at Homology Medicines Inc is Steven Gillis, 67, who is the Independent Director.
Albert's mailing address filed with the SEC is C/O HOMOLOGY MEDICINES, INC., ONE PATRIOTS PARK, BEDFORD, MA, 01730.
Over the last 7 years, insiders at Homology Medicines Inc have traded over $108,214,465 worth of Homology Medicines Inc stock and bought 3,033,333 units worth $51,999,993 . The most active insiders traders include Steven Gillis, James Edeerfield Management... és Kush Parmar. On average, Homology Medicines Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,785. The most recent stock trade was executed by Paul Alloway on 25 March 2024, trading 23,530 units of FIXX stock currently worth $21,883.
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Homology Medicines Inc executives and other stock owners filed with the SEC include: